急性心衰强化利尿时肾功能恶化与肾小管损伤无关
基于ROSE-AHF试验中283例急性心衰患者,分析强化利尿期间肾功能恶化(WRF)与肾小管损伤生物标志物的关联。结果显示WRF发生率为21.2%,与NGAL、NAG、KIM-1升高无关;而上述标志物升高反而与生存改善相关。提示强化利尿所致轻中度肾功能恶化不同于传统急性肾损伤。
要点
- 强化利尿期间WRF发生率为21.2%,与肾小管损伤标志物升高无关。
- NGAL、NAG、KIM-1升高反而与生存改善独立相关。
- 强化利尿所致轻中度肾功能恶化可能反映血流动力学变化而非肾小管损伤。
核心结论
- 在急性心衰强化利尿背景下,肾功能恶化与肾小管损伤生物标志物无关。
- 强化利尿常见的轻中度肾功能恶化不同于传统急性肾损伤机制。
研究设计与样本
- 多中心ROSE-AHF试验的事后分析,纳入283例有基线和72小时尿肾小管损伤标志物的急性心衰患者。
- WRF定义为基于胱抑素C估算的肾小球滤过率下降≥20%。
- 所有患者按方案接受大剂量袢利尿剂治疗。
主要发现
- NAG和KIM-1水平在强化利尿后无变化(均P>0.59),NGAL轻微下降(-8.7 ng/mg,IQR -169至35 ng/mg,P<0.001)。
- WRF发生率为21.2%,与NGAL(P=0.21)、NAG(P=0.46)、KIM-1(P=0.22)升高均无关。
- NGAL、NAG、KIM-1每升高10百分位与生存改善相关(校正HR 0.80,95%CI 0.69-0.91,P=0.001)。
临床怎么用
- 急性心衰强化利尿期间出现的轻中度肾功能恶化不应简单归因于肾小管损伤。
- 肾小管损伤标志物升高可能提示较好预后,但需进一步验证。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Worsening renal function (WRF) in the setting of aggressive diuresis for acute heart failure treatment may reflect renal tubular injury or simply indicate a hemodynamic or functional change in glomerular filtration. Well-validated tubular injury biomarkers, N-acetyl-β-d-glucosaminidase, neutrophil gelatinase-associated lipocalin, and kidney injury molecule 1, are now available that can quantify the degree of renal tubular injury. The ROSE-AHF trial (Renal Optimization Strategies Evaluation-Acute Heart Failure) provides an experimental platform for the study of mechanisms of WRF during aggressive diuresis for acute heart failure because the ROSE-AHF protocol dictated high-dose loop diuretic therapy in all patients. We sought to determine whether tubular injury biomarkers are associated with WRF in the setting of aggressive diuresis and its association with prognosis. METHODS: Patients in the multicenter ROSE-AHF trial with baseline and 72-hour urine tubular injury biomarkers were analyzed (n=283). WRF was defined as a ≥20% decrease in glomerular filtration rate estimated with cystatin C. RESULTS: Consistent with protocol-driven aggressive dosing of loop diuretics, participants received a median 560 mg IV furosemide equivalents (interquartile range, 300-815 mg), which induced a urine output of 8425 mL (interquartile range, 6341-10 528 mL) over the 72-hour intervention period. Levels of N-acetyl-β-d-glucosaminidase and kidney injury molecule 1 did not change with aggressive diuresis (both P>0.59), whereas levels of neutrophil gelatinase-associated lipocalin decreased slightly (-8.7 ng/mg; interquartile range, -169 to 35 ng/mg; P<0.001). WRF occurred in 21.2% of the population and was not associated with an increase in any marker of renal tubular injury: neutrophil gelatinase-associated lipocalin (P=0.21), N-acetyl-β-d-glucosaminidase (P=0.46), or kidney injury molecule 1 (P=0.22). Increases in neutrophil gelatinase-associated lipocalin, N-acetyl-β-d-glucosaminidase, and kidney injury molecule 1 were paradoxically associated with improved survival (adjusted hazard ratio, 0.80 per 10 percentile increase; 95% confidence interval, 0.69-0.91; P=0.001). CONCLUSIONS: Kidney tubular injury does not appear to have an association with WRF in the context of aggressive diuresis of patients with acute heart failure. These findings reinforce the notion that the small to moderate deteriorations in renal function commonly encountered with aggressive diuresis are dissimilar from traditional causes of acute kidney injury.
引用
- Ahmad T, Jackson K, Rao VS, et al. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury. Circulation. 2018. PMID: 29352071. doi:10.1161/CIRCULATIONAHA.117.030112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。